Showing 11-15 of 63 :
Leveraging Real-World Data for Precision Obesity Treatment

Listen to the full podcast >> Healtheconmoncs.com July 26, 2023 On this episode of tHEORetically speaking features Gary Curhan, Chief Medical Officer and Jessica Paulus, Vice President of Research at OM1, as they answer questions on Leveraging Real-World Data for Precision Obesity Treatment.

OM1 Launches Parkinson’s Disease Premium Dataset to Expand Real-World Evidence in Neuroscience

Read the full press release >> BOSTON–(BUSINESS WIRE)–OM1, the leading real-world data and technology company focused on chronic conditions, today announced the launch of its Parkinson’s Disease (PD) premium dataset and the enhancement of its Mental Health & Neuroscience Real-World Data Network. The dataset includes more than 7,000 patients prospectively followed by neurologists in hundreds of clinics across[…]

12 New Ways Companies Are Helping to Improve Adherence

PM360 July 13, 2023 Read the full article>> Reasons for Discontinuation (RfD) Analytics Report An estimated 50% of patients with a prescription for a chronic condition stop taking it within the first year, leading to worse outcomes and nearly $250 billion lost revenue annually for the pharmaceutical industry. To combat this, OM1 launched its Reasons for Discontinuation[…]

How Real-World Data Can Contribute to Improved Mental Health Treatment

PM360 MAY 25, 2023 Andrew Matthius Read the full article>> Mental health continues to be a national crisis that is only becoming more prevalent, especially since the pandemic. According to the National Alliance on Mental Illness (NAMI), 22.8% of U.S. adults experienced mental illness in 2021, which represents about 1 in 5 adults or 57.8 million[…]